Percentage and absolute number of tumor-specific CD44hiCD62L+CD8+T cells were not increased after transfer of 2DG treated non-CD8 immune cells compared to transfer of PBS treated non-CD8 immune cells in the mice treated with MWA + PBS (Fig. 4i). The gene discussed is CD8A; the disease is neoplasm.